Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2024-12-09 4:00 pm Purchase |
2024-12-02 | 13G | NeuroSense Therapeutics Ltd. NRSN |
Rimon Gold Assets Ltd | 2,303,729 9.990% |
2,303,729 (New Position) |
Filing History |
| 2024-02-13 1:20 pm Purchase |
2023-12-31 | 13G | NeuroSense Therapeutics Ltd. NRSN |
Gordon Ariel | 1,060,561 6.900% |
7,674 (+0.73%) |
Filing History |
| 2024-02-13 10:14 am Purchase |
2023-12-31 | 13G | NeuroSense Therapeutics Ltd. NRSN |
Ben-Noon Alon | 3,072,600 19.980% |
36,000 (+1.19%) |
Filing History |
| 2023-04-05 08:02 am Purchase |
2022-12-31 | 13G | NeuroSense Therapeutics Ltd. NRSN |
Ben-Noon Alon | 3,036,600 25.770% |
36,000 (+1.20%) |
Filing History |
| 2023-03-15 3:42 pm Purchase |
2022-12-31 | 13G | NeuroSense Therapeutics Ltd. NRSN |
Gordon Ariel | 1,052,887 8.920% |
15,480 (+1.49%) |
Filing History |
| 2023-03-15 3:32 pm Sale |
2022-01-11 | 13G | NeuroSense Therapeutics Ltd. NRSN |
E Europe Ltd | 0 0.000% |
-602,502 (Position Closed) |
Filing History |
| 2023-03-15 2:43 pm Purchase |
2022-01-11 | 13G | NeuroSense Therapeutics Ltd. NRSN |
Real Property International Ltd | 452,502 3.840% |
452,502 (New Position) |
Filing History |
| 2021-12-30 11:13 am Purchase |
2021-12-13 | 13G | NeuroSense Therapeutics Ltd. NRSN |
E Europe Ltd | 602,502 5.510% |
602,502 (New Position) |
Filing History |
| 2021-12-23 5:03 pm Purchase |
2021-12-13 | 13G | NeuroSense Therapeutics Ltd. NRSN |
Ben-Noon Alon | 3,000,600 27.420% |
3,000,600 (New Position) |
Filing History |
| 2021-12-20 4:40 pm Purchase |
2021-12-13 | 13G | NeuroSense Therapeutics Ltd. NRSN |
Gordon Ariel | 1,037,407 9.480% |
1,037,407 (New Position) |
Filing History |